Chi Sheng Pharma & Biotech Co., Ltd
Research Chi Sheng Pharma & Biotech Co., Ltd (4111.TWO) on Bullrun: market cap TWD 1.72B, P/E 9.2, dividend yield 4.5%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker4111.TWO
- ExchangeTWO
- CountryTaiwan
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyTWD
- Market capTWD 1.72B
- P/E9.2
- Dividend yield4.5%
- Financial periodQ2 2026
- RevenueTWD 375.11M
- Net incomeTWD 44.39M
- Free cash flowTWD 54.84M
- Gross margin37.8%
Valuation Snapshot
latest market cap is TWD 1.72B; P/E is 9.2; dividend yield is 4.5%.
Peer valuation comparison
Latest P/E is 9.19x versus a Healthcare sector median of 21.8x (57.9% below).
Latest dividend yield is 4.53% versus a Healthcare sector median of 2.41% (88.0% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | TWD 1.72B | 9.2 | 4.5% | 1.3 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 1.3 TWD, yield 4.5%.
About Chi Sheng Pharma & Biotech Co., Ltd
Chi Sheng Pharma & Biotech Co., Ltd manufactures, processes, imports, exports, and sells western medicines, cosmetics, health food products, medical devices, and animal medicines in Taiwan and internationally. Its product portfolio includes antibiotics and chemotherapeutic agents; plasma substitutes and amino acid preparations; water nutrients and electrolyte preparations; vitamins; hepatotropic agents; hormones and adrenal cortical steroids; autonomic nerve agents; antihistamines and antipruritics;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Chi Sheng Pharma & Biotech Co., Ltd's market cap?
Chi Sheng Pharma & Biotech Co., Ltd's market capitalization is TWD 1.72B.
What is Chi Sheng Pharma & Biotech Co., Ltd's P/E ratio?
Chi Sheng Pharma & Biotech Co., Ltd's price-to-earnings (P/E) ratio is 9.2.
Does Chi Sheng Pharma & Biotech Co., Ltd pay a dividend?
Chi Sheng Pharma & Biotech Co., Ltd has a dividend yield of 4.5%.
What does Chi Sheng Pharma & Biotech Co., Ltd do?
Chi Sheng Pharma & Biotech Co., Ltd manufactures, processes, imports, exports, and sells western medicines, cosmetics, health food products, medical devices, and animal medicines in Taiwan and internationally.